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De Novo Mutations in MLL Cause
Wiedemann-Steiner Syndrome
Wendy D. Jones,1,2,8 Dimitra Dafou,3,8 Meriel McEntagart,1 Wesley J. Woollard,3 Frances V. Elmslie,1
Muriel Holder-Espinasse,4,5 Melita Irving,5 Anand K. Saggar,1 Sarah Smithson,6 Richard C. Trembath,3,7
Charu Deshpande,5 and Michael A. Simpson3,*
Excessive growth of terminal hair around the elbows (hypertrichosis cubiti) has been reported both in isolation and in association with
a variable spectrum of associated phenotypic features.We identified a cohort of six individuals with hypertrichosis cubiti associated with
short stature, intellectual disability, and a distinctive facial appearance, consistent with a diagnosis of Wiedemann-Steiner syndrome
(WSS). Utilizing a whole-exome sequencing approach, we identified de novo mutations in MLL in five of the six individuals. MLL
encodes a histone methyltransferase that regulates chromatin-mediated transcription through the catalysis of methylation of histone
H3K4. Each of the five mutations is predicted to result in premature termination of the protein product. Furthermore, we demonstrate
that transcripts arising from the mutant alleles are subject to nonsense-mediated decay. These findings define the genetic basis of WSS,
provide additional evidence for the role of haploinsufficency of histone-modification enzymes in multiple-congenital-anomaly
syndromes, and further illustrate the importance of the regulation of histone modification in development.The non-androgen-related excessive growth of terminal
hair (hypertrichosis terminalis) may arise through conver-
sion of vellus hair to terminal hair, alteration of the hair
growth cycle, and increase in hair-follicle density.1
However, little is known about the molecular pathways
that control these biological processes. A localized form
of hypertrichosis terminalis of the extensor surfaces of
the distal upper arm and proximal forearm is known as hy-
pertrichosis cubiti and has also been termed the ‘‘hairy
elbows syndrome’’ (MIM 139600). Individuals have been
described with hypertrichosis cubiti both in isolation and
with a variable spectrum of associated phenotypic features
(reviewed in Polizzi et al.2 and Visser et al.3), including
several (but not all) individuals reported under the clinical
classification of Wiedemann-Steiner syndrome4,5 (WSS,
MIM 605130).
We sought to investigate the genetic basis of congenital
hypertrichosis cubiti using a whole-exome sequencing
approach. Given the heterogeneous spectrum of pheno-
typic features reported to be associated with hypertrichosis
cubiti, identification of a distinct disease phenotype
within this group was essential for this study. We defined
a discrete subgroupwho had hypertrichosis cubiti, intellec-
tual disability, a distinctive facial appearance (Figure 1),
and short stature, and we postulated that this phenotype
represented a single condition. This group is reminiscent
of a subset of reported WSS cases in which hypertrichosis
cubiti was observed. Six unrelated individuals with features
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trichosis cubiti or intellectual disability. Each family
provided full written consent, and ethical approval for
this study was obtained from Guy’s and St. Thomas’
National Health Service (NHS) Foundation Trust local
research ethics committee (ref.: 08/H0802/84, ‘‘Systematic
Characterization of Genes in Inherited Disorders’’).
DNAwas extracted from blood and the role of large-scale
chromosomal abnormalities was excluded in each of the
six cases (WSS-1–WSS-6) via comparative genomic hybrid-
ization (Agilent Human Genome CGH Microarray 44K:
WSS-1, WSS-2, WSS-3, and WSS-4; Agilent Human
Genome CGH Microarray 60K: WSS-5 and WSS-6; data
not shown). We therefore sought to identify disease-
causing alleles with the use of a whole-exome sequencing
strategy. Three micrograms of genomic DNA from four of
the six cases was sheared with the use of focused acoustic
technology (Covaris), which yielded a mean fragment
size of 150 bp. Fragments were end repaired and
sequencing adaptors were ligated. The sequence library
was hybridized for 24 hr with biotinylated 120 bp RNA
probes designed against coding regions of the genome
(Agilent). Streptavidin-coatedmagnetic beads were utilized
to retain DNA bound to the RNA probes, and unbound
DNA was washed off. The exome-enriched pool of DNA
was then eluted and amplified with a low-cycle PCR.
Finally, the enriched DNA fragments were sequenced
with 100 bp paired-end reads on the Illumina HiSeq2000.
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Figure 1. Clinical Images of Individuals in whom Mutations Were Identified in MLL
(A) Slim yet muscular build and the characteristic facial features, including long eyelashes, thick or arched eyebrows with a lateral flare,
and downslanting and vertically narrow palpebral fissures. A broad nasal bridge, a wide nasal tip, and a Cupid’s bow contour to the upper
lip are also seen.
(B) Hypertrichosis cubiti—excessive hair growth on the extensor surface of the distal upper arm and proximal forearm (individual
WSS-1).genome (hg19, National Center for Biotechnology Infor-
mation build 37) with Novoalign (Novocraft Technolo-
gies). Over 7.0 Gb of sequence was generated for each
subject, such that > 85% of the coding bases of the
GENCODE-defined exome were represented by at least
20 reads (Table S1 available online). Duplicate reads, result-
ing from PCR clonality or optical duplicates, and reads
mapping to multiple locations were excluded from the
downstream analysis. The depth and breadth of sequence
coverage was calculated with custom scripts and the
BedTools package.6 Single-nucleotide substitutions and
small insertion-deletion variants were identified with
SAMtools7 and annotated with respect to coding genes
with the ANNOVAR software package8 (Table S2).
We interrogated the exome variant profiles of the four
affected cases under the assumption that each of the caus-
ative alleles was dominant and had arisen de novo, high-
lighting candidate genes harboring at least one previously
unobserved heterozygous nonsynonymous or splice-site
substitution or a coding insertion or deletion in the same
gene in all four individuals. This process did not reveal
a single gene matching the criteria in all four individuals
(Table S3). However, evaluation of these data with a prior
expectation of genetic heterogeneity highlighted MLL
(MIM 159555) as the only candidate gene harboring
previously unobserved heterozygous variants in three of
the four subjects (Table S3): a four-nucleotide deletion
(WSS-1: c.8806_8809del [p.Val2936*]) and two single-
nucleotide deletions (WSS-2: c.8267del [p.Leu2756*],
WSS-3: c.6913del [p.Ser2305Leufs*2]) (Figure 2, Table 1).
The three observed variants inMLL are all located within
exon 27 of the 36-exon gene, which is located at chro-The Americmosome 11q23 and encodes a 16.6 kb transcript
(NM_001197104.1). Each is predicted to lead to the disrup-
tion of the reading frame, resulting in a predicted pre-
mature termination of the protein product with a high like-
lihood of functional impact (Figure 2). None of the
observed mutations are present in dbSNP, have been
observed by the 1000 Genomes Project, or were detected
in 600 unrelated control exome profiles. The variants
were confirmed with Sanger sequencing in the respective
probands. Moreover, none of the mutations were present
in unaffected parental DNA from leukocytes, consistent
with the notion that the disease-causing alleles have arisen
de novo.We sought to identify mutations inMLL in the re-
maining two individuals who met our clinical criteria.
Sequencing of the coding regions and associated splice sites
of MLL revealed a heterozygous variant in each subject;
each is predicted to lead to premature termination of the
protein product (WSS-5: c.7144C>T [p.Arg2382*], WSS-6:
c.4599dup [p.Lys1534*]). Neither mutation was observed
in the respective unaffected parental DNA from leukocytes.
In total, we investigated six individuals who met our clin-
ical criteria and identified mutations in five of them.
Following a reviewof the findings, it was evident on clinical
examination that hypertrichosis cubiti was observed in
conjunction with a homogeneous group of associated
features in the five individuals in whom we had identified
MLLmutations (Table 1): distinct, consistent facial charac-
teristics including long eyelashes, thick or arched eyebrows
with a lateral flare, and downslanting and vertically narrow
palpebral fissures (Figure 1); mild to moderate intellectual
disability; andbehavioral difficulties. In addition, thedistri-
bution of hair on the lower upper arm and upper forearman Journal of Human Genetics 91, 358–364, August 10, 2012 359
Table 1. Major Clinical and Genetic Findings in the Six Individuals in the Present Study
Individual
WSS-1 WSS-2 WSS-3 WSS-4 WSS-5 WSS-6
MLL nucleotide alteration c.8806_8809del c.8267del c.6913del  c.7144C>T c.4599dup
MLL amino-acid alteration p.Val2936* p.Leu2756* p.Ser2305Leufs*2  p.Arg2382* p.Lys1534*
Gender male female female male male female
Age at last examination (years) 6 8 12 5 8 24
Growth Parameters
Birth weight (centile) 75th 2nd–9th 0.4th–2nd 2nd–9th 9th 25th–50th
Head circumferencea (centile) 9th <0.4th 50th <0.4th <2nd 50th
Heighta (centile) 0.4th–2nd <0.4th 9th (GH) 2nd–9th 9th 0.4th–2nd
Weighta (centile) 2nd–9th <0.4th 25th 2nd–9th 2nd 25th
Facial Features
Eyebrow lateral flare þ þ    
Thick eyebrows þ  þ þ þ þ
Long eyelashes þ þ þ þ þ þ
Palpebral fissure, downslanted þ þ þ  þ þ
Palpebral fissure, vertically narrow þ þ þ  þ þ
Wide nasal bridge þ þ þ  þ þ
Broad nasal tip þ þ þ  þ þ
Cupid’s bow, exaggerated  þ þ  þ 
Upper vermillion border, thin þ   þ  þ
Musculoskeletal
Broad first digits þ    þ 
Tapering fingers  þ  þ þ þ
2–3 toe syndactyly  þ  þ þ 
Long hallux  þ   þ 
Slim and muscular build þ þ  þ þ 
Rib anomalies on X-ray þ U þ U þ 
Scoliosis      þ
Sacral dimple þ þ þ  U þ
Gastrointestinal
Constipation þ þ   þ 
Feeding difficulties þ þ  þ þ 
NG and PEG feeding þ þ    
Hair
Hypertrichosis cubiti þ þ þ  þ þ
Hypertrichosis, back þ þ þ þ þ þ
Hypertrichosis, lower limbs   þ   þ
Development and Behavior
Developmental delay moderate moderate moderate mild mild mild
Autism þ þ    
Aggressive behavior þ  þ  þ 
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Table 1. Continued
Individual
WSS-1 WSS-2 WSS-3 WSS-4 WSS-5 WSS-6
Poor sleep þ þ    
Hyperactivity    þ  
Cardiac
Cardiac anomaly  b  ASD b PDA
Investigations
Full blood count normal NA normal NA NA normal
þ, feature present; , feature absent; GH, growth hormone; U, unknown; NG, nasogastric; PEG, percutaneous endoscopic gastrostomy; ASD, atrial septal defect;
PDA, patent ductus arteriosus; NA, not assessed
aAt last examination.
bNormal clinical cardiac examination (has not had echocardiogram).was observed in combination with excessive hair on the
back with a whorl-like distribution. All five individuals
were < 10th centile for height, and a sacral dimple was
observed in four of the five. The affected individual
(WSS-4), in whom exome sequencing did not reveal any
potentially pathogenic variation in MLL, and high-resolu-
tion comparative genomic hybridization did not reveal
genomic abnormalities (affecting MLL or elsewhere in the
genome), presented some subtle phenotypic differences.
The hair on the arms was at the upper limit of normal and
was more diffuse than the hypertrichosis cubiti observed
in the five individualswithmutantMLL alleles. Hair growth
on the back was notably longer than that of the other five
cases (extending up to 12 cm in length). His facial features
also differed; downslanting palpebral fissures were absent.
Although this case may be explained by an allele
comprising a noncoding or undetected coding variant in
MLL, in light of the observed phenotypic differences, it is
reasonable to speculate that this individual most likelyFigure 2. Domain Structure of MLL and the Locations of the Obse
The identified mutations are each predicted to cause premature te
C-terminal region containing the FRYC motif, the Win motif, and th
The Americrepresents a phenotype within the spectrum of WSS for
which the molecular genetic basis is distinct from the five
cases in which mutations have been identified inMLL.
MLL encodes a histone methyltransferase that has been
demonstrated to regulate chromatin-mediated transcrip-
tion, including the transcription of multiple Hox and
Wnt genes, through the catalysis of mono-, di-, and trime-
thylation of histone H3K4.9 The large (3,969 aa), multido-
main MLL protein comprises three DNA binding AT-
hooks at the N terminus, followed by a cysteine-rich
CXXC domain, plant homeodomain finger motifs, a
bromo domain, a transactivation domain, a nuclear recep-
tor interactionmotif, aWDR5 interaction (Win)motif, and
a C-terminal SET domain, which is responsible for the
protein’s histone-methyltransferase activity.10 The mature
MLL is proteolytically processed at two independent sites
(CS1, aa 2666–2667 and CS2, aa 2718–2719; Figure 2), and
the cleaved C- and N-terminal fragments form a stable
complex that localized to a subnuclear compartment.11rved Mutations
rmination of the protein product before the translation of the
e SET domain.
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Figure 3. Total Abundance of MLL Transcript in Primary Skin
Fibroblasts from WSS-3 and the Average of Two Unrelated
Healthy Controls
MLL expression normalized to endogenous GAPDH and RPLO
expression levels. Error bars represent SEM of three independent
experiments. UHC, unrelated healthy controls.The identified mutations were each predicted to cause
premature termination of the protein product, leading to
a mature protein product lacking the SET domain and,
therefore, histone-methyltransferase activity (Figure 2).
To establish whether the mutant MLL alleles are subject
to nonsense-mediated decay, we used a quantitative real-
time PCR approach (Kapa Biosystems) performed on
a 7900HT Fast Real-Time PCR System (Life Technologies)
to assess the total abundance ofMLL transcripts in primary
skin fibroblast cells derived from individual WSS-3, hetero-
zygous for the c.6913del allele. We observed that the level
of MLL transcript is reduced in comparison to unrelated
healthy controls (Figure 3), consistent with the notion
that transcripts arising from the mutant MLL alleles are
subject to nonsense-mediated decay.
MLL is widely expressed in most cell types,12 but it has
been most extensively studied in the context of hemato-
logical malignancies. The MLL locus has been reported
as the site of somatic chromosome translocations in
acute myeloid, acute lymphoblastoid, or mixed-lineage
leukemia, and more than 50 different fusion partners
have been identified. In mice, homozygosity for MLL
null alleles is embryonically lethal.13 However, heterozy-
gous mice were demonstrated to be viable; they were small
at birth and had retarded growth.13 These observations in
the haploinsufficient murine model are consistent with
birth weight in the lower range (4/5 individuals, <10th
centile, Table 1), subsequent growth retardation, and
height in the lower range (5/5 individuals, <10th centile,
Table 1) in our cohort of individuals with heterozygous
mutations in MLL. The heterozygous mice were also re-
ported to be anemic and have decreased platelets, although
the morphology of hematopoietic cells was normal.
Immune function has not been fully investigated in our
cohort; basic hematological investigations (full blood
count), where available, had normal results (Table 1).
However, it may be of potential functional importance
that individual WSS-1 had a history of recurrent infections
in childhood. Given the intellectual disability in all the
individuals in whom we identified mutations in MLL362 The American Journal of Human Genetics 91, 358–364, August 1(Table 1), it is of note that MLL also has a demonstrated
neuronal function and has been shown to be required for
neurogenesis in the postnatal brain.14
MLL demonstrates homology to other proteins with
histone-methylation activity, including MLL2 (MIM
602113).15 Recently, several studies have reported an
allelic series of heterozygous nonsense and frameshift
mutations in MLL2 in individuals diagnosed with Kabuki
syndrome (MIM 147920), a multiple-anomaly syndrome
that is also associated with short stature, feeding diffi-
culties, intellectual disability, and a distinctive facial
appearance, including unusual eyebrows and long
eyelashes.16–19 Furthermore, de novo truncating and
missense mutations in CREBBP (MIM 600140), which
encodes a protein with histone-acetyltransferase activity
that has also previously been demonstrated to interact
with MLL,20 underlie Rubinstein Taybi syndrome,21 and
de novo truncatingmutations in the gene encoding SRCAP
(MIM 611421), a coactivator of CREBBP, are responsible for
Floating Harbor syndrome22 (MIM 180849). Both of these
multiple-anomaly disorders overlap phenotypically with
WSS, including postnatal growth restriction, hypertricho-
sis, and intellectual disability.
The distinct phenotype observed in individuals in
whom we have identified de novo MLL mutations is
similar to that of certain individuals reported in the WSS
literature. Specifically, the individual reported by Steiner
and Marques4 and the individuals reported by Koenig
et al.5 all had hypertrichosis, intellectual disability,
and similar facial characteristics, including thick or
arched eyebrows and downslanting and vertically narrow
palpebral fissures. Within the WSS literature, there is
substantial phenotypic variation; taken together with the
fact that one of our six cases (WSS-4) does not harbor
a mutation inMLL, these findings suggest that haploinsuf-
ficiency of MLL may underlie a distinct clinical and
genetic entity within the WSS spectrum. Further investiga-
tion of the pathogenic role of MLL in a wider cohort of
individuals with WSS and other congenital forms of
hypertrichosis cubiti is needed to fully delineate the
phenotypic spectrum associated with mutations in this
gene.
In summary, we have identified the causal role of MLL
haploinsufficiency in a subset of individuals with hypertri-
chosis cubiti who have additional phenotypic features
that are consistent with a diagnosis of WSS. The features
observed in these individuals, including the excessive
growth of terminal hair, are probably the result of
secondary downstream effects on transcription via dis-
ruption of the genomic distribution and the timing of
histone-methylation events. Our findings provide addi-
tional evidence to the growing body of research that has
demonstrated the role of haploinsuficiency of histone-
modification enzymes in multiple-congenital-anomaly
disorders16,23–25 and reinforce the important role that
epigenetic control, and chromatin modification in partic-
ular, plays in both human development and disease.0, 2012
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